Guangdong Marubi Biotechnology Co (603983) - Total Liabilities
Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has total liabilities worth CN¥1.20 Billion CNY (≈ $174.94 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Guangdong Marubi Biotechnology Co asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Guangdong Marubi Biotechnology Co - Total Liabilities Trend (2011–2025)
This chart illustrates how Guangdong Marubi Biotechnology Co's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Guangdong Marubi Biotechnology Co assets under control.
Guangdong Marubi Biotechnology Co Competitors by Total Liabilities
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Publishing & Media Hldg
SHG:601949
|
China | CN¥5.06 Billion |
|
ORG Packaging Co Ltd
SHE:002701
|
China | CN¥21.10 Billion |
|
ASBISc Enterprises PLC
WAR:ASB
|
Poland | zł928.10 Million |
|
Hainan Haide Industry Co Ltd
SHE:000567
|
China | CN¥3.21 Billion |
|
Origin Bancorp, Inc.
NYSE:OBK
|
USA | $9.00 Billion |
|
Guangdong Rongtai Industry Co Ltd
SHG:600589
|
China | CN¥3.01 Billion |
|
SJM HOLDINGS UNSP.ADR/4
F:3MG1
|
Germany | €37.42 Billion |
|
Unisem M Bhd
KLSE:5005
|
Malaysia | RM915.72 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Guangdong Marubi Biotechnology Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Guangdong Marubi Biotechnology Co net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Marubi Biotechnology Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Marubi Biotechnology Co (2011–2025)
The table below shows the annual total liabilities of Guangdong Marubi Biotechnology Co from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.22 Billion ≈ $178.42 Million |
-24.55% |
| 2024-12-31 | CN¥1.62 Billion ≈ $236.48 Million |
+56.11% |
| 2023-12-31 | CN¥1.04 Billion ≈ $151.48 Million |
+23.44% |
| 2022-12-31 | CN¥838.64 Million ≈ $122.72 Million |
+39.04% |
| 2021-12-31 | CN¥603.19 Million ≈ $88.26 Million |
-24.07% |
| 2020-12-31 | CN¥794.44 Million ≈ $116.25 Million |
+3.66% |
| 2019-12-31 | CN¥766.40 Million ≈ $112.15 Million |
+4.27% |
| 2018-12-31 | CN¥735.02 Million ≈ $107.56 Million |
+14.31% |
| 2017-12-31 | CN¥643.00 Million ≈ $94.09 Million |
-0.74% |
| 2016-12-31 | CN¥647.79 Million ≈ $94.79 Million |
-0.32% |
| 2015-12-31 | CN¥649.88 Million ≈ $95.10 Million |
+8.77% |
| 2014-12-31 | CN¥597.49 Million ≈ $87.43 Million |
+22.90% |
| 2013-12-31 | CN¥486.14 Million ≈ $71.14 Million |
+3.47% |
| 2012-12-31 | CN¥469.82 Million ≈ $68.75 Million |
+4.65% |
| 2011-12-31 | CN¥448.94 Million ≈ $65.69 Million |
-- |
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands. The company was founded in 2002 and is based in Guangzhou, China.